NCT07219407Phase 2Recruiting

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Study sponsor: Rapport Therapeutics Inc. · RAPP

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-02-03Estimated
Enrollment · participants30Estimated
Source updated2026-11-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source